SOMCT02 Huntington’s disease trial recruits 100% of patient target

Roche: less frequent dosing for Phase 3 Huntington’s clinical trial, easing...

Amendment to the RG6042 Phase III GENERATION HD1 study design

An Updated Trial Design for Roche’s Huntingtin Lowering Trial

sRNAlytics Receives FDA Support for AI-Powered Pathway Analytics Platform

Roche ramps up Huntington’s disease clinical trial for early- to mid-stage...

When interrupting is good: genetic hiccups that protect against Huntington’s disease

At last, hope for families living in the shadow of Huntington’s...

uniQure Presents New Preclinical Data on AMT-130 at the CHDI’s 14th...

Mitochon Pharmaceuticals Awarded Orphan Drug Designation

1234...120Page 3 of 120